Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SEAGEN-INC-10808/news/Seagen-Announces-ADCETRIS-brentuximab-vedotin-Plus-Novel-Immunotherapy-Combination-Delivers-98-44097692/?utm_source=whatsapp&utm_medium=social&utm_campaign=share